A scientific study conducted at the University of Basrah has revealed a novel treatment derived from camel blood plasma.
A research team from the College of Veterinary Medicine, comprising Dr. Nameer Abdul-Karim Khudair, Dr. Muhannad Faris Abdul- Hamid, and MSc student Hussein Radi Taama, published a study titled “Camel Plasma: An Innovative Treatment for Colibacillosis in Lambs.”
The study, published in the Veterinary World (a Q1-ranked journal indexed in Scopus), aimed to evaluate camel blood plasma as a new therapeutic option for treating Escherichia coli infection in newborn lambs. It also compared the effectiveness of camel plasma with antibiotics, camel milk, and commercial probiotics to support sustainable livestock production and reduce zoonotic diseases.
The findings demonstrated a clear therapeutic advantage of camel plasma, showing superior effectiveness in improving clinical symptoms and modulating inflammatory responses compared to conventional treatments. Additionally, it significantly enhanced passive immunity in infected lambs and offered a promising non-antibiotic approach to combating microbial resistance, thereby helping to limit the spread of antimicrobial resistance (AMR).
Media and Government Communication Division
College of Veterinary Medicine
University of Basrah